Unlike the treatment of cancer cells, where such cytotoxicity is taken advantage of, treatment of tau aggregated neuron cells by drug loaded carriers require detailed attention towards these two points (cytotoxicity and exocytosis) because such carriers are to deliver their cargo to the live neuron cells and recover those. This evidence concerns the gene MAPT and cancer.